EIF4E and glioblastoma: Antitumor effects of merestinib in GBM lines and patient-derived mesenchymal glioma stem cell lines are related to the inhibition of eIF4E phosphorylation and a decrease in global protein synthesis and cyclin D1/D2 translation [81].